The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Murkamilov I.T.

Akhunbaev Kyrgyz State Medical Academy;
First President of Russia B.N. Yeltsin Kyrgyz Russian Slavic University

Aitbaev K.A.

Research Institute of Molecular Biology and Medicine

Fomin V.V.

Sechenov University

Hakimov Sh.Sh.

Akhunbaev Kyrgyz State Medical Academy

Shchendrigin I.N.

State Medical University

Solizhonov J.I.

Kazan State Medical University

Yusupova T.F.

Osh State University

Yusupova Z.F.

Osh State University

Yusupov F.A.

Osh State University

Functional state of the kidneys in patients with various types of cerebrovascular diseases

Authors:

Murkamilov I.T., Aitbaev K.A., Fomin V.V., Hakimov Sh.Sh., Shchendrigin I.N., Solizhonov J.I., Yusupova T.F., Yusupova Z.F., Yusupov F.A.

More about the authors

Read: 976 times


To cite this article:

Murkamilov IT, Aitbaev KA, Fomin VV, et al. . Functional state of the kidneys in patients with various types of cerebrovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(1):105‑111. (In Russ.)
https://doi.org/10.17116/jnevro2025125011105

Recommended articles:
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Painful diabetic poly­neuropathy in patients with cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):64-72

References:

  1. Gusev EI, Skvortsova VI, Martynov MYu, et al. Cerebral apoplexy: problems and solutions. Vestnik RGMY=RSMU Herald. 2006;(4):28-36. (In Russ.).
  2. Kamchatnov PR, Kabanov AA. The efficiency and safety of secondary prevention of ischemic stroke. The Clinician. 2013;7(2):73-80. (In Russ.).
  3. Gerdt AM, Shutov AM, Menzorov MV, et al. Causal relationships in stroke and kidney injury. Therapeutic Archive. 2017;89(6):62-68. (In Russ.). https://doi.org/10.17116/terarkh201789662-68
  4. Drapkina OM, Shishkova VM, Kotova MB. Psychoemotional risk factors for non-communicable diseases in outpatient practice. Guidelines for internists. Cardiovascular Therapy and Prevention. 2022;21(10):3438. (In Russ.). https://doi.org/10.15829/1728-8800-2022-3438
  5. Kobiakova OS, Deev IA, Kulikov ES, et al. Chronic noncommunicable diseases: combined effects of risk factors. Russian Journal of Preventive Medicine. 2019;22(2):45-50. (In Russ.). https://doi.org/10.17116/profmed20192202145
  6. Moiseev VS, Mukhin NA, Smirnov AV, et al. Cardiovascular risk and cardionephroprotection strategies. Clinical nephrology. 2014;2:4-29. (In Russ.).
  7. Murkamilov IT, Sabirov IS, Murkamilova ZhA et al. Prevalence of risk factors for cerebrovascular diseases in patients with end-stage renal disease. Clinical Nephrology. 2022;3:39-51. (In Russ.). https://doi.org/10.18565/nephrology.2022.3.39-51
  8. Murkamilov IT, Aitbaev KA, Fomin VV, et al. Stroke in patients with urolithiasis: prevalence and risk factors. The Scientific Heritage. 2020;47-2(47):40-44. (In Russ.).
  9. Clinical recommendations. Chronic kidney disease (CKD). Nephrology (Saint-Petersburg). 2021;25(5):10-82. (In Russ.).
  10. Dedov II, Shestakova MV, Mayorov AY, et al. Diabetes mellitus type 2 in adults. Diabetes mellitus. 2020;23(2S):4-102. (In Russ.). https://doi.org/10.14341/DM12507
  11. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.). https://doi.org/10.15829/1560-4071-2020-3-3786
  12. Martsevich SYu, Tolpygina SN, Chernysheva MI, et al. Clinical characteristics and long-term survival of patients with an acute cerebrovascular event and chronic heart failure, according to outpatient follow-up registry REGION-M. Russian Journal of Preventive Medicine. 2022;25(8):14-20. (In Russ.). https://doi.org/10.17116/profmed20222508114
  13. Ginsberg MD. The cerebral collateral circulation: Relevance to pathophysiology and treatment of stroke. Neuropharmacology. 2018;134(Pt B):280-292.  https://doi.org/10.1016/j.neuropharm.2017.08.003
  14. Gudkova VV, Usanova EV, Stakhovskaya LV. Diabetes Mellitus and Stroke: from Pathophisiology to Therapeutic Management. Lechebnoe delo. 2013;4:83-89. (In Russ.).
  15. Bruno A, Leibeskind D, Hao Q, et al. Diabetes mellitus, acute hyperglycemia, and ischemic stroke. Cur Treat Opt in Neurology. 2010;12:492-503.  https://doi.org/10.1007/s11940-010-0093-6
  16. Dedov II, Shestakova MV. Cerebral vascular lesions in diabetes mellitus: solved and unresolved questions. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8):79-82. (In Russ.). https://doi.org/10.17116/jnevro20151156179-82
  17. Voznyuk IA, Shamalov NA, Ezhov MV, et al. Optimization of lipid-lowering therapy in patients after ischemic stroke. Resolution of the Council of Experts. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6):152-161. (In Russ.). https://doi.org/10.17116/jnevro2020120061152
  18. Mukhin NA, Fomin VV, Damulin IV, et al. Chronic kidney disease and vascular dementia. Therapeutic Archive. 2014;86(6):7-10. (In Russ.).
  19. Khrulev AE, Nikitina AA, Khruleva NS. Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period. Cardiovascular Therapy and Prevention. 2019;18(3):88-93. (In Russ.). https://doi.org/10.15829/1728-8800-2019-3-88-93
  20. Shakhmatova OO, Komarov AL, Krivosheeva EN, et al. Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(9):763-768. (In Russ.). https://doi.org/10.26442/00403660.2023.09.202434
  21. Aitbaev KA, Murkamilov IT, Fomin VV, et al. New data on the pathophysiology of ischemic stroke: epigenetic mechanisms in focus. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(12-2):24-29. (In Russ.). https://doi.org/10.17116/jnevro202312312224
  22. Bernoud-Hubac N, Lo Van A, Lazar AN, et al. Ischemic Brain Injury: Involvement of Lipids in the Pathophysiology of Stroke and Therapeutic Strategies. Antioxidants (Basel). 2024;13(6):634.  https://doi.org/10.3390/antiox13060634
  23. Back C, Thiesen KL, Skovgaard K, et al. RAAS and stress markers in acute ischemic stroke: preliminary findings. Acta Neurol Scand. 2015;131(2):132-139.  https://doi.org/10.1111/ane.12298
  24. Bochkarev MV, Korostovtseva LS, Medvedeva EA, et al. Sleep disorders and stroke: data of the ESSE-RF study. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(4-2):73-80. (In Russ.). https://doi.org/10.17116/jnevro201911904273
  25. Kuzmenko NV, Galagudza MM, Fedorenko AA, et al. Seasonal dynamics of cardiovascular events in the Russian Federation. Russian Journal of Cardiology. 2024;29(6):5773. (In Russ.). https://doi.org/10.15829/1560-4071-2024-5773
  26. Panchenko MG, Gasanov MZ, Batyushin MM, et al. Clinical and pathogenetic features of the development of endothelial dysfunction in patients with chronic kidney disease and its contribution to the development of cognitive impairments. Nephrology (Saint-Petersburg). 2024;28(2):43-54. (In Russ.). https://doi.org/10.36485/1561-6274-2024-28-2-43-54
  27. Kamchatnov PR, Vorob’eva OV, Rachin AP. Treatment of emotional and cognitive disorders in patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(4):52-56. (In Russ.).
  28. Zhuravleva MV, Kamchatnov PR, Vasyukova NS, et al. Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11):29-39. (In Russ.). https://doi.org/10.17116/jnevro202212211129

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.